Biotech Consulting

Areas of Expertise

  • Oncology small molecule inhibitor development
  • Target identification and validation strategy
  • Pipeline prioritization and evaluation of in-licensing opportunities
  • Predictive and pharmacodynamic biomarker identification
  • Biomarker assay development strategy
  • CRO identification for clinical biomarker implementation, including liquid biopsies
  • Evaluation of bioinformatics workflows and strategies
  • Scientific writing, including preclinical sections of regulatory and clinical documents

Summary of Qualifications

  • 10+ years of industry experience in big pharma and small biotech settings ranging from early discovery to phase 2 clinical development of molecularly targeted small molecules
  • Experience building companies, departments, and teams from the ground up, including multi-functional teams across discovery and translational biology, bioinformatics, and in vivo pharmacology from research associate to director level
  • Successfully translated novel biological findings into the clinic to support clinical programs with differentiated biomarker strategies as translational lead for several small molecule inhibitor programs
  • Preclinical oncology expertise with broad practical experience in epigenetics, chromatin biology, kinase biology, signal transduction, synthetic lethality, immuno-oncology, and identification of mechanisms of resistance to targeted therapeutics
  • Please see my LinkedIn page for additional details, and my CV is available upon request